Recurrent and Metastatic Head and Neck Cancer

Patients treated for head and neck cancers have a high rate of loco-regional recurrence and metastases. The current standards of care are largely based on institutional data or small multi-institutional retrospective collaborative series. There is a need to highlight some of the challenges in the management of these complex patients and present an expert consensus on the treatment and care of these patients. This session will serve to bring together experts in radiation oncology, head and neck surgery and medical oncology to educate the audience on various aspects of management of patients with recurrent and metastatic head and neck cancers with lectures and case-base discussion.

 

Target Audience

    This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.

     

    Learning Objectives

    Upon completion of this activity, participants should be able to do the following:

    • Identify the challenges in the management of recurrent and metastatic head and neck cancer patients.
    • Describe the role and strategies for re-irradiation and surgical salvage in local and regionally recurrent head and neck cancers.
    • Describe the role of novel therapies and immunotherapy in the treatment of metastatic head and neck cancers.
    Course summary
    Available credit: 
    • 1.00 AMA PRA Category 1 Credit™
      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    Course opens: 
    02/11/2022
    Course expires: 
    02/26/2025
    Cost:
    $0.00
    Part of: 
    2022 Multidisciplinary Head and Neck Cancers Symposium onDemand
    Rating: 
    0

    Neil Dunlap, MD, is employed by the University of Louisville and has no financial relationships with a commercial interest.

    Urjeet Patel, is employed by Northwestern Hospital and has no financial relationships with a commercial interest.

    Christine Chung, MD is employed by Moffitt Cancer Center and has no financial relationships with a commercial interest.

    All relevant relationships have been mitigated.

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

     

    Available Credit

    • 1.00 AMA PRA Category 1 Credit™
      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.

    Price

    Cost:
    $0.00
    Please login or register to take this course.